Co-Chief Executive Officer
Sandra is a life sciences executive, strategist, and investor with more than 25 years of experience driving transformation and long-term value creation. As Co-CEO of Therakos, she leads corporate strategy, enterprise transformation, and clinical development for one of the world’s pioneering cell therapy platforms.
Sandra previously served as Co-CEO of Therakos, repositioning the company and advancing the scientific and regulatory foundation of extracorporeal photopheresis (ECP)—culminating in the first regulatory approval for ECP in Japan. She is the founder of VitalShift, a life sciences advisory firm, where she partnered with private equity firms as a board member and operating partner for more than 15 years. Earlier in her career, Sandra held executive roles in the healthcare, technology and consumer products industries including Johnson & Johnson, Caremark RX, and Unisys.
Sandra currently serves on the Board of Trustees for the World Doctors’ Orchestra.
Sandra holds a Bachelor of Science from The Pennsylvania State University, with graduate studies and executive education certifications from St Joseph’s University, Harvard Medical School, and the Wharton School of The University of Pennsylvania.